tyrosine has been researched along with o-(2-fluoroethyl)tyrosine in 119 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (1.68) | 18.2507 |
2000's | 51 (42.86) | 29.6817 |
2010's | 61 (51.26) | 24.3611 |
2020's | 5 (4.20) | 2.80 |
Authors | Studies |
---|---|
Heiss, P; Herz, M; Schwaiger, M; Senekowitsch-Schmidtke, R; Stöcklin, G; Weber, W; Wester, HJ | 1 |
Heiss, P; Herz, M; Mayer, S; Schwaiger, M; Senekowitsch-Schmidtke, R; Wester, HJ | 1 |
Dzewas, B; Feldmann, HJ; Grosu, AL; Herz, M; Molls, M; Schwaiger, M; Stöcklin, G; Weber, WA; Wester, HJ | 1 |
Buck, A; Gottschalk, J; Kaim, AH; Kurrer, MO; Schweitzer, A; von Schulthess, GK; Weber, B; Westera, G | 1 |
Becker, I; Herz, M; Krüger, A; Rau, FC; Schwaiger, M; Senekowitsch-Schmidtke, R; Weber, WA; Wester, HJ | 1 |
Gan, M; Luo, L; Tang, G; Tang, X; Wang, M | 2 |
Coenen, HH; Floeth, F; Hamacher, K; Herzog, H; Langen, KJ; Müller, HW; Pauleit, D; Tellmann, L | 1 |
Bröer, S; Coenen, HH; Hamacher, K; Jansen, P; Jarosch, M; Langen, KJ; Mühlensiepen, H; Zilles, K | 1 |
Cheng, X; Dang, YH; Wang, SZ; Zhou, Q | 1 |
Coenen, HH; Floeth, F; Hamacher, K; Hautzel, H; Langen, KJ; Müller, HW; Pauleit, D; Tellmann, L | 1 |
Gan, MQ; Luo, L; Tang, GH; Tang, XL; Wang, MF | 1 |
Gildehaus, FJ; Götz, C; Pöpperl, G; Rachinger, W; Tatsch, K; Tonn, JC | 1 |
Aguzzi, A; Buck, A; Hermann, DM; Kaser-Hotz, B; Lutz, A; Pahnke, J; Radovanovic, I; Scheidegger, S; Spaeth, N; Verwey, J; Weber, B; Weishaupt, D; Westera, G; Wild, D; Wyss, MT | 1 |
Coenen, HH; Hamacher, K; Kloska, S; Kurlemann, G; Langen, KJ; Rickert, CH; Schober, O; Straeter, R; Wassmann, H; Weckesser, M | 1 |
Coenen, HH; Floeth, F; Hamacher, K; Langen, KJ; Müller, HW; Pauleit, D; Reifenberger, G; Riemenschneider, MJ; Zilles, K | 1 |
Coenen, H; Floeth, FW; Hamacher, K; Langen, KJ; Messing-Jünger, M; Müller, HW; Pauleit, D; Reifenberger, G; Sabel, M; Steiger, HJ; Stummer, W; Weber, F; Wittsack, HJ; Woebker, G; Zilles, K | 1 |
Bauer, D; Bröer, S; Coenen, HH; Hamacher, K; Herzog, H; Langen, KJ; Pauleit, D; Schaden, W; Stoffels, G; Tellmann, L | 1 |
Gildehaus, FJ; Goldbrunner, R; Holtmannspötter, M; Kreth, FW; Pöpperl, G; Tanner, P; Tatsch, K; Tonn, JC | 1 |
Chang, CW; Chen, JC; Hwang, JJ; Hwang, LC; Lee, TW; Liu, RS; Wang, HE; Wu, SY | 1 |
Bauer, D; Coenen, HH; Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Stoffels, G; Zilles, K | 1 |
Bauer, D; Coenen, HH; Flüss, MO; Hamacher, K; Langen, KJ; Pauleit, D; Risse, J; Stoffels, G; Zimmermann, A | 1 |
Gildehaus, FJ; Herms, J; Koch, W; Kreth, FW; Kretzschmar, HA; Mehrkens, JH; Pöpperl, G; Tatsch, K; Tonn, JC | 1 |
Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT | 1 |
Gildehaus, FJ; Götz, C; Pöpperl, G; Rachinger, W; Schnell, O; Tatsch, K; Tonn, JC | 1 |
Herz, M; Schwaiger, M; Seidl, C; Senekowitsch-Schmidtke, R; Stöber, B; Tanase, U | 1 |
Bauer, D; Coenen, HH; Floeth, F; Hamacher, K; Langen, KJ; Pauleit, D; Stoffels, G; Weckesser, M | 1 |
Fukumoto, D; Kakiuchi, T; Sato, K; Tsukada, H | 1 |
Amthauer, H; Denecke, T; Felix, R; Feussner, A; Gneveckow, U; Gutberlet, M; Jordan, A; Meier-Hauff, K; Plotkin, M; Wust, P | 1 |
Deng, WP; Gelovani, JG; Hwang, JJ; Lin, M; Liu, RS; Wang, HE; Wei, HJ; Yu, HM | 1 |
Coenen, HH; Hamacher, K; Langen, KJ; Pauleit, D; Reifenberger, G; Sabel, M; Salber, D; Shah, NJ; Stoffels, G | 1 |
Abe, K; Hayashi, K; Himuro, K; Honda, H; Kaneko, K; Koga, H; Sasaki, M; Sawamoto, H | 1 |
Bauer, R; Brust, P; Fischer, S; Ganapathy, V; Herzau, M; Hinz, R; Huggel, K; Makrides, V; Opfermann, T; Verrey, F; Weber, W; Wester, HJ | 1 |
Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT | 1 |
Bärtschi, E; Hefti, M; Hofer, S; Roelcke, U; Treyer, V; Uhlmann, C; Wyss, MT | 1 |
Gildehaus, FJ; Herms, J; Koch, W; Kreth, FW; Kretzschmar, HA; Mehrkens, JH; Pöpperl, G; Seelos, K; Tatsch, K; Tonn, JC | 1 |
Coenen, HH; Hamacher, K; Klauth, P; Langen, KJ; Oros-Peusquens, AM; Pauleit, D; Salber, D; Shah, NJ; Stoffels, G | 1 |
Herms, J; Kreth, FW; Mehrkens, JH; Pöpperl, G; Rachinger, W; Seelos, K; Tatsch, K; Tonn, JC | 1 |
Floeth, FW; Hamacher, K; Langen, KJ; Pauleit, D; Sabel, M; Steiger, HJ; Stoffels, G | 1 |
Buchfelder, M; Ganslandt, O; Kuwert, T; Linke, R; Nimsky, C; Prante, O; Salomonowitz, E; Stadlbauer, A | 1 |
Fischman, AJ | 1 |
Alauddin, MM; Flores, LG; Gelovani, JG; Mukhopadhyay, U; Shavrin, A; Soghomonyan, S; Volgin, AY; Yeh, HH | 1 |
Buck, AK; Eckel, F; Friess, H; Herrmann, K; Kleeff, J; Krause, BJ; Scheidhauer, K; Schmid, RM; Schmidt, S; Schuster, T; Schwaiger, M; Wester, HJ | 1 |
Miralbell, R; Ratib, O; Senthamizhchelvan, S; Vees, H; Weber, DC; Zaidi, H | 1 |
Bogner, L; Eilles, C; Koelbl, O; Rickhey, M | 1 |
Basu, S | 1 |
Bärtschi, E; Bruehlmeier, M; Buettner, UW; Hefti, M; Hofer, S; Roelcke, U; Uhlmann, C; Wyss, M | 1 |
Buchfelder, M; Doelken, M; Ganslandt, O; Kuwert, T; Linke, R; Nimsky, C; Pölking, E; Prante, O; Stadlbauer, A | 1 |
Fonyuy, N; Horn, P; Koch, A; Misch, M; Plotkin, M; Stockhammer, F | 1 |
Ahn, SH; Cheon, GJ; Choi, CW; Chun, KS; Kang, JH; Lee, TS; Lim, SM; Moon, BS | 1 |
Bachofner, A; Coenen, HH; Floeth, FW; Hamacher, K; Herzog, H; Jansen, P; Langen, KJ; Pauleit, D; Reifenberger, G; Sabel, M; Stoffels, G; Tellmann, L | 1 |
Alfteimi, A; Forstner, CV; Henze, E; Lützen, U; Meller, B; Zuhayra, M | 1 |
Attieh, C; Demirel, C; Eble, MJ; Holy, R; Kaiser, HJ; Langen, KJ; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
Callahan, J; Drummond, E; Drummond, KJ; Grigg, A; Hicks, RJ; Hogg, A; Lau, EW; Ryan, G; Ware, RE | 1 |
Benouaich-Amiel, A; Bousquet, P; Cances-Lauwers, V; Clanet, M; Delisle, MB; Esquerré, JP; Gantet, P; Julian, A; Lubrano, V; Payoux, P; Roux, F; Sabatier, J; Sol, JC; Tafani, M; Tremoulet, M; Uro-coste, E | 1 |
Aigner, RM; Dunzinger, A; Nussbaumer, K; Pichler, J; Pichler, R; Topakian, R; Weis, S; Wurm, G | 1 |
Bogner, L; Eilles, C; Koelbl, O; Morávek, Z; Rickhey, M | 1 |
Kalev, O; Nussbaumer, K; Pichler, R; Silyé, R; Weis, S; Wurm, G | 1 |
Doostkam, S; Meckel, S; Meyer, PT; Nikkhah, G; Prinz, M; Reithmeier, T; Rottenburger, C | 1 |
Altieri, S; Bortolussi, S; Burchielli, S; Del Guerra, A; Del Turco, S; Matteucci, M; Menichetti, L; Panetta, D; Pascali, G; Petroni, D; Salvadori, PA | 1 |
Coenen, HH; Eble, MJ; Galldiks, N; Herzog, H; Holy, R; Kaiser, HJ; Langen, KJ; Pinkawa, M; Piroth, MD; Stoffels, G | 1 |
Astner, ST; Grosu, AL; Heinemann, F; Molls, M; Nieder, C; Riedel, E; Schwaiger, M; Weber, WA; Wester, HJ; Wiedenmann, N | 1 |
Gotwald, T; Hutterer, M; Jacobs, AH; Kostron, H; Muigg, A; Nowosielski, M; Putzer, D; Staffen, W; Stockhammer, G; Tinkhauser, G; Trinka, E; Virgolini, IJ; Waitz, D | 1 |
Bourdier, T; Faragalla, J; Greguric, I; Jackson, T; Katsifis, A; Roselt, P | 1 |
Baum, RP; Kalb, F; Klette, I; Mueller, D | 1 |
Buchfelder, M; Dörfler, A; Ganslandt, O; Grummich, P; Hammen, T; Kuwert, T; Nimsky, C; Stadlbauer, A | 1 |
Coenen, HH; Eble, MJ; Galldiks, N; Holy, R; Kaiser, HJ; Klotz, J; Langen, KJ; Pinkawa, M; Piroth, MD; Schaar, S; Stoffels, G | 1 |
Jeong, SY; Lim, SM | 1 |
Coenen, HH; Filss, CP; Fink, GR; Galldiks, N; Herzog, H; Langen, KJ; Piroth, MD; Ruge, MI; Sabel, M; Shah, NJ; Stoffels, G | 1 |
Belka, C; Büsing, K; Eigenbrod, S; Ganswindt, U; Geisler, J; Jansen, N; la Fougère, C; Niyazi, M; Schnell, O; Schwarz, SB | 1 |
Brown, RC; Gibson, AM; Isoni, V; Khan, I; Logothetis, TA; Perrio, C; Topley, AC; Wadsworth, H; Wells, NJ; Wynn, D | 1 |
Göbel, G; Hutterer, M; Jacobs, AH; Jansen, NL; la Fougère, C; McCoy, M; Nowosielski, M; Putzer, D; Schocke, M; Seiz, M; Stockhammer, G; Trinka, E; Virgolini, IJ | 1 |
Bartenstein, P; Belka, C; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; la Fougère, C; Lutz, J; Schwarz, SB; Suchorska, B | 1 |
Coenen, HH; Eble, MJ; Geisler, S; Langen, KJ; Piroth, MD; Prasath, J; Sellhaus, B; Shah, NJ; Stoffels, G; van Osterhout, A; Willuweit, A | 1 |
Burger, U; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Habermehl, D; Hoffmann, C; Rief, H; Rieken, S; Welzel, T | 1 |
Coenen, HH; Eble, MJ; Galldiks, N; Langen, KJ; Liebenstund, S; Piroth, MD; Shah, NJ; Stoffels, G | 1 |
Coenen, HH; Erdem, Z; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Reifenberger, G; Ruge, MI; Sabel, M; Shah, NJ; Stoffels, G | 1 |
Coenen, HH; Filss, C; Galldiks, N; Herzog, H; Langen, KJ; Neuner, I; Rota Kops, E; Shah, NJ; Stoffels, G; Tellmann, L; Zhang, K | 1 |
Flentje, M; Polat, B; Reiners, C; Samnick, S; Sweeney, R; Verburg, FA | 1 |
Berberat, J; Boxheimer, L; Bruehlmeier, M; Nitzsche, EU; Rahm, V; Remonda, L; Roelcke, U | 1 |
Driever, PH; Grosse, F; Guggemos, A; Koch, A; Misch, M; Plotkin, M; Steffen, IG; Thomale, UW | 1 |
Coenen, HH; Cornelius, JF; el Khatib, M; Felsberg, J; Filß, C; Galldiks, N; Hänggi, D; Kamp, M; Langen, KJ; Sabel, M; Shah, NJ; Slotty, P; Steiger, HJ; Stoffels, G | 1 |
Boissel, JP; Closs, EI; Graf, J; Habermeier, A; Roesch, F; Sandhöfer, BF | 1 |
Blau, T; Dorn, F; Drzezga, A; Dunkl, V; Fink, GR; Galldiks, N; Goldbrunner, R; Hau, P; Herrlinger, U; Hutterer, M; Kebir, S; Kocher, M; Langen, KJ; Rapp, M; Reifenberger, G; Ruge, MI; Sabel, M; Schmidt, M; Stoffels, G | 1 |
Andersen, SB; Bøgeskov, L; Cleff, C; Coenen, HH; Dunkl, V; Fink, GR; Galldiks, N; Judov, N; Langen, KJ; Law, I; Nysom, K; Reifenberger, G; Sarikaya-Seiwert, S; Shah, NJ; Steiger, HJ; Stoffels, G | 1 |
Costa, J; Engelholm, S; Engelholm, SA; Law, I; Lundemann, MJ; Munck Af Rosenschold, P; Ohlhues, L | 1 |
Bette, S; Buchmann, N; Förster, S; Gempt, J; Meyer, B; Peschke, P; Pyka, T; Ringel, F; Ryang, YM; Wester, HJ | 1 |
Coenen, HH; Filss, C; Galldiks, N; Herzog, H; Judov, N; Langen, KJ; Lohmann, P; Rota Kops, E; Sabel, M; Shah, NJ; Stoffels, G; Tellmann, L; Weiss, C | 1 |
Blau, T; Ceccon, G; Dunkl, V; Filss, C; Fink, GR; Galldiks, N; Langen, KJ; Rapp, M; Sabel, M; Shah, NJ; Stoffel, M; Stoffels, G; Tscherpel, C; Weinzierl, M | 1 |
Coenen, HH; Filss, C; Galldiks, N; Langen, KJ; Oliveira, D; Schöneck, M; Shah, NJ; Stegmayr, C; Willuweit, A | 1 |
Fimmers, R; Galldiks, N; Glas, M; Herrlinger, U; Kebir, S; Langen, KJ; Mack, F; Niessen, M; Schäfer, N; Schaub, C; Scheffler, B; Simon, M; Stoffels, G; Stuplich, M; Tzaridis, T | 1 |
Bette, S; Delbridge, C; Foerster, S; Gempt, J; Huber, T; Kirschke, JS; Meyer, B; Pyka, T; Ringel, F; Schlegel, J; Zimmer, C | 1 |
Eble, MJ; Ermert, J; Galldiks, N; Holy, R; Langen, KJ; Mottaghy, FM; Pinkawa, M; Piroth, MD; Shah, NJ; Stoffels, G | 1 |
Bauer, E; Ceccon, G; Filss, CP; Fink, GR; Galldiks, N; Hamisch, C; Judov, N; Kocher, M; Kuchelmeister, K; Langen, KJ; Lohmann, P; Rapp, M; Ruge, MI; Sabel, M; Sellhaus, B; Shah, NJ; Stoffels, G | 1 |
Af Rosenschöld, PM; Christensen, IJ; Grunnet, K; Jensen, ML; Larsen, VA; Law, I; Poulsen, HS; Poulsen, SH; Urup, T | 1 |
Albert, NL; Bartenstein, P; Brendel, M; Kreth, FW; Muacevic, A; Nachbichler, SB; Romagna, A; Schmid-Tannwald, C; Tonn, JC; Unterrainer, M | 1 |
Chan, M; Hsiao, E | 1 |
Albert, NL; Bartenstein, P; Belka, C; Fleischmann, DF; Niyazi, M; Unterrainer, M | 1 |
Costa, JC; Engelholm, SA; Law, I; Lundemann, M; Muhic, A; Munck Af Rosenschold, P; Poulsen, HS | 1 |
Arbizu, J; Galldiks, N; Langen, KJ; Law, I; Pope, WB | 1 |
Combs, SE; Debus, J; Dittmar, A; Dittmar, JO; Giesel, FL; Haberkorn, U; Habermehl, D; Kratochwil, C; Rieken, S; Welzel, T | 1 |
Eickhoff, SB; Fink, GR; Galldiks, N; Guedj, E; Langen, KJ; Lohmann, P; Shah, NJ; Stegmayr, C; Stoffels, G; Van Der Gucht, A; Verger, A | 1 |
Buck, AK; Ernestus, RI; Hänscheid, H; Kertels, O; Kessler, AF; Kleinlein, I; Lapa, C; Linsenmann, T; Löhr, M; Mihovilovic, MI; Monoranu, CM; Samnick, S | 1 |
Bartek, J; Daxberg, EL; Förander, P; Gempt, J; Jakola, AS; Laesser, M; Liljegren, A; Näslund, O; Smits, A | 1 |
Amunts, K; Galldiks, N; Geisler, S; Langen, KJ; Lohmann, P; Mohlberg, H; Oros-Peusquens, AM; Piroth, MD; Sellhaus, B; Shah, NJ; Weis, J | 1 |
Burghaus, L; Deckert, M; Fink, GR; Galldiks, N; Kabbasch, C; Langen, KJ; Ruge, MI | 1 |
Bock, M; Bott, S; Grosu, AL; Mader, I; Meyer, PT; Mix, M; Nestle, U; Nieder, C; Oehlke, O; Popp, I; Schimek-Jasch, T; Urbach, H; Weber, WA; Yuh, WTC | 1 |
Buchmann, N; Gempt, J; Kirschke, JS; Meyer, B; Pyka, T; Ringel, F; Ryang, YM | 1 |
Abdollahi, A; Afshar-Oromieh, A; Debus, C; Debus, J; Floca, R; Haberkorn, U; Ingrisch, M; Knoll, M | 1 |
Engelholm, S; Engelholm, SA; Grunnet, K; Law, I; Lundemann, MJ; Muhic, A; Munck Af Rosenschold, P; Roed, H; Skovgaard Poulsen, H | 1 |
Basse, V; Bourhis, D; Dissaux, G; Querellou, S; Seizeur, R | 1 |
Langen, KJ; Lohmann, P; Stegmayr, C; Willuweit, A | 1 |
Galldiks, N; Langen, KJ; Lindemeyer, J; Lohmann, P; Neumaier, B; Shah, NJ; Shymanskaya, A; Stoffels, G; Worthoff, WA | 1 |
Boellaard, R; De Witt Hamer, PC; Hoekstra, OS; Koopman, T; Lammertsma, AA; Pouwels, PJ; Verburg, N; Wesseling, P; Yaqub, M | 1 |
Brumberg, J; Ernestus, RI; Kertels, O; Kessler, AF; Kircher, M; Lapa, C; Linsenmann, T; Löhr, M; Meyer, PT; Mihovilovic, MI; Monoranu, CM; Samnick, S; Tran-Gia, J | 1 |
Brunn, A; Fink, GR; Galldiks, N; Langen, KJ | 1 |
Brucker, DP; Filipski, K; Filss, CP; Galldiks, N; Hattingen, E; Langen, KJ; Maurer, GD; Mottaghy, FM; Steinbach, JP; Stoffels, G | 1 |
Filss, CP; Fink, GR; Galldiks, N; Goldbrunner, R; Langen, KJ; Lohmann, P; Mottaghy, FM; Neumaier, B; Rapp, M; Sabel, M; Schmitz, AK; Shah, NJ; Stegmayr, C; Stoffels, G; Werner, JM | 1 |
Bauer, EK; Baues, C; Ceccon, G; Celik, E; Fink, GR; Galldiks, N; Gielen, GH; Herrlinger, U; Kabbasch, C; Langen, KJ; Lohmann, P; Marnitz, S; Schäfer, N; Schaub, C; Stoffels, G; Tscherpel, C; Weller, J; Werner, JM | 1 |
5 review(s) available for tyrosine and o-(2-fluoroethyl)tyrosine
Article | Year |
---|---|
O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.
Topics: Animals; Biological Transport; Brain Neoplasms; Fluorine Radioisotopes; Humans; Positron-Emission Tomography; Tyrosine | 2006 |
PET imaging of brain tumors.
Topics: Biopsy; Brain; Brain Neoplasms; Cell Proliferation; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lipids; Medical Oncology; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2008 |
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.
Topics: Amino Acids; Brain Neoplasms; Dihydroxyphenylalanine; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2017 |
Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.
Topics: Brain Neoplasms; Carbon Radioisotopes; Glioma; Humans; Methionine; Positron-Emission Tomography; Preoperative Period; Radiopharmaceuticals; Tyrosine | 2018 |
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Fluorine Radioisotopes; Humans; Medical Oncology; Microvessels; Radiopharmaceuticals; Tyrosine | 2019 |
18 trial(s) available for tyrosine and o-(2-fluoroethyl)tyrosine
Article | Year |
---|---|
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Methionine; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tyrosine | 2000 |
Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Methyltyrosines; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tyrosine | 2004 |
Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
Topics: Brain Neoplasms; Fluorine Radioisotopes; Glioma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2004 |
O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2005 |
PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.
Topics: Adult; Aged; Feasibility Studies; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2005 |
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
Topics: Antineoplastic Agents; Brain Neoplasms; Convection; Drug Delivery Systems; Female; Glioblastoma; Humans; Infusions, Intralesional; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2005 |
18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Tyrosine | 2006 |
Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Topics: Adult; Algorithms; Brain; Brain Neoplasms; Computer Simulation; Female; Glioma; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Severity of Illness Index; Tyrosine | 2006 |
Serial O-(2-[(18)F]fluoroethyl)-L: -tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma.
Topics: Adult; Brachytherapy; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radioimmunotherapy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Tyrosine | 2006 |
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Magnetics; Male; Middle Aged; Nanostructures; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Tyrosine | 2006 |
Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients.
Topics: Adult; Aged; Female; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Tumor Burden; Tyrosine | 2009 |
Early metabolic responses in temozolomide treated low-grade glioma patients.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Fluorine Radioisotopes; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Temozolomide; Time Factors; Tyrosine; Young Adult | 2009 |
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
Topics: Adolescent; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Tyrosine; Young Adult | 2009 |
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tyrosine | 2009 |
Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma.
Topics: Brain; Brain Neoplasms; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Positron-Emission Tomography; Prospective Studies; Tyrosine | 2010 |
Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.
Topics: Adult; Aged; Brain; Chemoradiotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Prospective Studies; Quality of Life; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Supratentorial Neoplasms; Tyrosine | 2012 |
Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.
Topics: Adult; Aged; Brain Neoplasms; Dideoxynucleosides; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Prospective Studies; Tyrosine | 2012 |
Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.
Topics: Adult; Aged; Chemoradiotherapy; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tumor Burden; Tyrosine | 2016 |
96 other study(ies) available for tyrosine and o-(2-fluoroethyl)tyrosine
Article | Year |
---|---|
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Topics: Animals; Astrocytoma; Brain Neoplasms; Chromatography, High Pressure Liquid; Colonic Neoplasms; Female; Humans; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Transplantation; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Tyrosine | 1999 |
Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
Topics: Animals; Biological Transport; Contrast Media; Fluorine Radioisotopes; Humans; Kinetics; Mice; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Tyrosine | 1999 |
(18)F-FDG and (18)F-FET uptake in experimental soft tissue infection.
Topics: Abscess; Animals; Autoradiography; Carbon Radioisotopes; Deoxyglucose; Fluorodeoxyglucose F18; Leg; Leukocytes; Myositis; Radionuclide Imaging; Radiopharmaceuticals; Rats; Reference Values; Staphylococcal Infections; Tyrosine | 2002 |
O-(2-[(18)F]Fluoroethyl)- L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes.
Topics: Animals; Diagnosis, Differential; Fluorodeoxyglucose F18; Foot; Lymphadenitis; Lymphatic Metastasis; Lymphoma, T-Cell; Male; Methionine; Mice; Mice, Inbred BALB C; Neoplasm Staging; Neoplasm Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Soft Tissue Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Tyrosine | 2002 |
Pharmacokinetics and radiation dosimetry estimation of O-(2-[18F]fluoroethyl)-L-tyrosine as oncologic PET tracer.
Topics: Animals; Fluorine Radioisotopes; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Pharmacokinetics; Radiation Dosage; Radiometry; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Tumor Cells, Cultured; Tyrosine | 2003 |
Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine.
Topics: Adult; Brain Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Tyrosine; Whole-Body Counting | 2003 |
Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas.
Topics: Animals; Autoradiography; Brain; Brain Neoplasms; Cell Line, Tumor; Glioma; Male; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tissue Distribution; Tissue Transplantation; Tyrosine | 2003 |
[Synthesis and preliminary studies of O-(2-[18F] fluoroethyl)-L-tyrosine as a positron emission tomography imaging agent].
Topics: Adult; Animals; Brain Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Humans; Male; Mice; Middle Aged; Sarcoma 180; Tomography, Emission-Computed; Tyrosine | 2002 |
Synthesis and evaluation of O-(3-[18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer.
Topics: Animals; Fibrosarcoma; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Isotope Labeling; Mice; Myositis; Organ Specificity; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tyrosine | 2003 |
[Synthesis and radiopharmacology of S-(2-18F-fluoroethyl)-L-methionine for tumor imaging].
Topics: Animals; Fluorodeoxyglucose F18; Inflammation; Methionine; Mice; Neoplasm Transplantation; Radiopharmaceuticals; Sarcoma 180; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Tyrosine | 2003 |
Uptake of 18F-fluorocholine, 18F-fluoroethyl-L-tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence.
Topics: Acute Disease; Animals; Brain; Brain Injuries; Brain Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Necrosis; Neoplasm Recurrence, Local; Quaternary Ammonium Compounds; Radiation Injuries, Experimental; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tyrosine | 2004 |
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Child; Child, Preschool; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Tyrosine | 2005 |
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Energy Metabolism; Female; Fluorine Radioisotopes; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuronavigation; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2005 |
Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Topics: Animals; Boron Compounds; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glycopeptides; Metabolic Clearance Rate; Molecular Probe Techniques; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Tissue Distribution; Tyrosine | 2005 |
Evaluation of new 18F-labeled amino acids for brain PET.
Topics: Animals; Autoradiography; Brain; Brain Chemistry; Brain Diseases; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Proline; Rats; Tyrosine | 2005 |
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Glioma; Male; Metabolic Clearance Rate; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tyrosine | 2006 |
Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.
Topics: Cells, Cultured; Colonic Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Humans; Inflammation; Metabolic Clearance Rate; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2006 |
Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice.
Topics: Animals; Drug Evaluation, Preclinical; Female; Fluorine Radioisotopes; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Positron-Emission Tomography; Radiopharmaceuticals; Stereoisomerism; Tissue Distribution; Tyrosine | 2006 |
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Female; Floxuridine; Fluorodeoxyglucose F18; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Mice; Neoplasms; Prodrugs; Thymidine Kinase; Tyrosine | 2006 |
Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia.
Topics: Animals; Brain Ischemia; Cerebral Cortex; Fluorine Radioisotopes; Male; Methionine; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tritium; Tyrosine | 2006 |
O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) uptake in mouse thymoma cells, and its biodistribution in mice and human volunteers.
Topics: Adult; Analysis of Variance; Animals; Fluorine Radioisotopes; Humans; Male; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Thymoma; Tyrosine; Whole-Body Counting | 2006 |
Preferred transport of O-(2-[18F]fluoroethyl)-D-tyrosine (D-FET) into the porcine brain.
Topics: Adult; Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Positron-Emission Tomography; Stereoisomerism; Swine; Tissue Distribution; Tyrosine | 2007 |
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
Topics: Animals; Antibodies; Brain Neoplasms; Cell Line, Tumor; Choline; Fibronectins; Glioma; Male; Neovascularization, Pathologic; Radiopharmaceuticals; Rats; Rats, Wistar; Recombinant Fusion Proteins; Tyrosine | 2007 |
Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake.
Topics: Adult; Amino Acid Transport Systems; Brain Neoplasms; Capillaries; Cerebellum; Female; Fluorine Radioisotopes; Glioma; Humans; Male; Microcirculation; Middle Aged; Oxygen Isotopes; Oxygen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine; Water | 2007 |
FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tyrosine | 2007 |
Differential uptake of O-(2-18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses.
Topics: Animals; Blood-Brain Barrier; Brain Abscess; Deoxyglucose; Fluorine Radioisotopes; Male; Methionine; Radiopharmaceuticals; Rats; Rats, Inbred F344; Tritium; Tyrosine | 2007 |
The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cell Proliferation; Combined Modality Therapy; Disease Progression; Female; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Stereotaxic Techniques; Tyrosine | 2008 |
Prognostic value of 18F-fluoroethyl-L-tyrosine PET and MRI in small nonspecific incidental brain lesions.
Topics: Adolescent; Adult; Aged; Brain; Child; Disease Progression; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Tyrosine | 2008 |
Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2-18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging.
Topics: Adult; Aged; Cell Membrane; Cerebrum; Energy Metabolism; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurons; Positron-Emission Tomography; Protons; Tyrosine | 2008 |
N(3)-Substituted thymidine analogues V: synthesis and preliminary PET imaging of N(3)-[(18)F]fluoroethyl thymidine and N(3)-[(18)F]fluoropropyl thymidine.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Thymidine; Tissue Distribution; Tyrosine | 2008 |
In vivo characterization of proliferation for discriminating cancer from pancreatic pseudotumors.
Topics: Adult; Aged; Diagnosis, Differential; Female; Granuloma, Plasma Cell; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2008 |
A biologically adapted dose-escalation approach, demonstrated for 18F-FET-PET in brain tumors.
Topics: Aged; Brain Neoplasms; Feasibility Studies; Female; Fluorine Radioisotopes; Glioblastoma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Monte Carlo Method; Positron-Emission Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tyrosine | 2008 |
Selecting the optimal image segmentation strategy in the era of multitracer multimodality imaging: a critical step for image-guided radiation therapy.
Topics: Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Radioactive Tracers; Radiotherapy, Computer-Assisted; Sensitivity and Specificity; Tyrosine | 2009 |
Detection of tumour invasion into the pyramidal tract in glioma patients with sensorimotor deficits by correlation of (18)F-fluoroethyl-L: -tyrosine PET and magnetic resonance diffusion tensor imaging.
Topics: Adult; Aged; Brain; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Male; Middle Aged; Movement Disorders; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Pyramidal Tracts; Radiography; Sensation Disorders; Sensitivity and Specificity; Tyrosine | 2009 |
Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.
Topics: Adult; Aged; Aminolevulinic Acid; Biomarkers, Tumor; Brain Neoplasms; Female; Fluorescence; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Neuronavigation; Neurosurgical Procedures; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Tyrosine | 2009 |
Comparison of 18F-FDG, 18F-FET and 18F-FLT for differentiation between tumor and inflammation in rats.
Topics: Animals; Diagnosis, Differential; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Inflammation; Neoplasms; Positron-Emission Tomography; Rats; Thymidine Phosphorylase; Tissue Distribution; Tyrosine | 2009 |
New approach for the synthesis of [18F]fluoroethyltyrosine for cancer imaging: simple, fast, and high yielding automated synthesis.
Topics: Automation; Chromatography, Gas; Neoplasms; Radiopharmaceuticals; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tyrosine | 2009 |
Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour.
Topics: Adult; Aged; Brain; Brain Neoplasms; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Glioma; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radioisotopes; Reproducibility of Results; Sensitivity and Specificity; Tyrosine; Young Adult | 2010 |
Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?
Topics: Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiography; Retrospective Studies; Tyrosine | 2010 |
18F-FET-PET-based dose painting by numbers with protons.
Topics: Algorithms; Brain Neoplasms; Fluorine Radioisotopes; Glioblastoma; Humans; Linear Energy Transfer; Monte Carlo Method; Photons; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tyrosine | 2010 |
Sarcoidois and radiation-induced astrogliosis causes pitfalls in neuro-oncologic positron emission tomography imaging by O-(2-[18F]fluoroethyl)-L-tyrosine.
Topics: Adult; Aged; Astrocytes; Brain Diseases; Humans; Male; Positron-Emission Tomography; Radiation Injuries; Radiopharmaceuticals; Sarcoidosis; Tyrosine | 2010 |
Interesting image. Amino acid PET tracer accumulation in cortical ischemia: an interesting case.
Topics: Brain Ischemia; Humans; Male; Middle Aged; Positron-Emission Tomography; Radioactive Tracers; Tyrosine | 2010 |
A micro-PET/CT approach using O-(2-[18F]fluoroethyl)-L-tyrosine in an experimental animal model of F98 glioma for BNCT.
Topics: Animals; Boron Neutron Capture Therapy; Brain Neoplasms; Disease Models, Animal; Glioma; Multimodal Imaging; Positron-Emission Tomography; Rats; Tomography, X-Ray Computed; Tyrosine | 2011 |
Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Contrast Media; Cranial Irradiation; Dacarbazine; Dose Fractionation, Radiation; Female; Fluorine Radioisotopes; Gadolinium DTPA; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Prospective Studies; Survival Rate; Temozolomide; Treatment Outcome; Tumor Burden; Tyrosine | 2011 |
An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Topics: Brain; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Time Factors; Tumor Burden; Tyrosine | 2011 |
O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Combined Modality Therapy; Disease-Free Survival; Female; Glioma; Humans; Image Processing, Computer-Assisted; Irinotecan; Magnetic Resonance Imaging; Male; Middle Aged; Nervous System Diseases; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Treatment Failure; Tyrosine; Ultrasonography | 2011 |
Fully automated one-pot radiosynthesis of O-(2-[18F]fluoroethyl)-L-tyrosine on the TracerLab FX(FN) module.
Topics: Automation; Indicators and Reagents; Laboratories; Quality Control; Radiochemistry; Reproducibility of Results; Tyrosine | 2011 |
Synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine based on a cartridge purification method.
Topics: Chromatography, High Pressure Liquid; Ethanol; Tyrosine | 2011 |
Classification of peritumoral fiber tract alterations in gliomas using metabolic and structural neuroimaging.
Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Fluorine Radioisotopes; Glioma; Humans; Magnetic Resonance Imaging; Male; Medical Oncology; Middle Aged; Nervous System Diseases; Neurology; Neurons; Positron-Emission Tomography; Prognosis; Tyrosine | 2011 |
Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
Topics: Adolescent; Adult; Aged; Biological Transport; Brain Neoplasms; Diagnosis, Differential; Humans; Male; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries; ROC Curve; Tyrosine; Young Adult | 2012 |
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Survival Rate; Tyrosine; Young Adult | 2012 |
A Resin-linker-vector approach to radiopharmaceuticals containing 18F: application in the synthesis of O-(2-[18F]-fluoroethyl)-L-tyrosine.
Topics: Amino Acids; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Kinetics; Molecular Structure; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Tyrosine | 2013 |
[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood-Brain Barrier; Brain Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2013 |
[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma.
Topics: Brachytherapy; Disease-Free Survival; Glioma; Humans; Iodine; Magnetic Resonance Imaging; Positron-Emission Tomography; Tyrosine | 2013 |
Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.
Topics: Animals; Biological Transport; Brain; Brain Neoplasms; Cell Line, Tumor; False Positive Reactions; Glioma; Gliosis; Male; Positron-Emission Tomography; Rats; Tyrosine | 2013 |
Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tyrosine; Young Adult | 2013 |
Monitoring of radiochemotherapy in patients with glioblastoma using O-(2-¹⁸Fluoroethyl)-L-tyrosine positron emission tomography: is dynamic imaging helpful?
Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Female; Fluorine Radioisotopes; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tyrosine | 2013 |
Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.
Topics: Adolescent; Adult; Biological Transport; Child; Disease Progression; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Regression Analysis; Tyrosine; Young Adult | 2013 |
Relationship of regional cerebral blood flow and kinetic behaviour of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake in cerebral gliomas.
Topics: Adult; Aged; Biological Transport; Brain Neoplasms; Cerebrovascular Circulation; Female; Glioma; Humans; Kinetics; Male; Middle Aged; Positron-Emission Tomography; Tyrosine | 2014 |
O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Time Factors; Tyrosine; Young Adult | 2014 |
Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas.
Topics: Adult; Aged; Amino Acids; Brain Neoplasms; Cerebellar Neoplasms; Cerebellum; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tyrosine | 2014 |
(18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Male; Neuronavigation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2015 |
Uptake and tracer kinetics of O-(2-(18)F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Kinetics; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2015 |
System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
Topics: Animals; Cell Line, Tumor; Contrast Media; Fusion Regulatory Protein 1, Heavy Chain; Glioblastoma; Humans; Large Neutral Amino Acid-Transporter 1; Neoplasm Proteins; Positron-Emission Tomography; Radiography; Tyrosine; Xenopus laevis | 2015 |
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; False Positive Reactions; Female; Glioblastoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2015 |
The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tyrosine | 2015 |
Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Tyrosine; Young Adult | 2015 |
18F-fluoro-ethyl-tyrosine positron emission tomography for grading and estimation of prognosis in patients with intracranial gliomas.
Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Tyrosine | 2015 |
Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Physical Examination; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tyrosine | 2015 |
The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.
Topics: Brain Neoplasms; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tyrosine | 2015 |
Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.
Topics: Animals; Biological Transport; Brain Neoplasms; Dexamethasone; Disease Models, Animal; Glioma; Kinetics; Male; Positron-Emission Tomography; Rats; Reproducibility of Results; Tyrosine | 2016 |
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tyrosine; Young Adult | 2016 |
Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Topics: Adult; Biomarkers, Tumor; Brain; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tumor Burden; Tyrosine | 2016 |
Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Tyrosine; Young Adult | 2017 |
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed; Tyrosine | 2017 |
Suspected recurrence of brain metastases after focused high dose radiotherapy: can [
Topics: Brachytherapy; Brain Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiosurgery; ROC Curve; Tyrosine | 2016 |
Neurosarcoidosis on FET and FDG PET/CT.
Topics: Adult; Brain Neoplasms; Central Nervous System Diseases; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tyrosine | 2017 |
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Immunological; Bevacizumab; Brain Neoplasms; Female; Glioma; Humans; Karnofsky Performance Status; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Nonlinear Dynamics; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Re-Irradiation; Survival Analysis; Time Factors; Tyrosine; Young Adult | 2017 |
Patterns of failure for patients with glioblastoma following O-(2-[
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy, Image-Guided; Retrospective Studies; Treatment Failure; Tyrosine | 2017 |
First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas.
Topics: Adult; Aged; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neuroimaging; Octreotide; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2017 |
Evaluation of factors influencing
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Brain; Brain Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sex Factors; Tyrosine; Young Adult | 2018 |
O-(2-(
Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult | 2019 |
Correlation of Dynamic O-(2-[
Topics: Brain; Brain Neoplasms; Combined Modality Therapy; Fatal Outcome; Glioblastoma; Humans; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine | 2018 |
FET PET in Primary Central Nervous System Vasculitis.
Topics: Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine; Vasculitis, Central Nervous System | 2018 |
Diffusion-weighted MRI and ADC versus FET-PET and GdT1w-MRI for gross tumor volume (GTV) delineation in re-irradiation of recurrent glioblastoma.
Topics: Adult; Aged; Brain Neoplasms; Diffusion Magnetic Resonance Imaging; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiosurgery; Re-Irradiation; Tumor Burden; Tyrosine | 2019 |
Can Early Postoperative O-(2-
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Electroencephalography; Evoked Potentials, Somatosensory; Female; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Tomography Scanners, X-Ray Computed; Tyrosine | 2019 |
Feasibility and robustness of dynamic
Topics: Aged; Antineoplastic Agents; Brain Neoplasms; Carbon; Female; Glioma; Heavy Ion Radiotherapy; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Statistical; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Temozolomide; Tyrosine | 2018 |
Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients.
Topics: Adult; Brain Neoplasms; Glioblastoma; Humans; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Treatment Outcome; Tumor Burden; Tyrosine | 2019 |
Uptake and Tracer Kinetic of O-(2-(18)F-fluoroethyl)-L-Tyrosine in Meningioma.
Topics: Aged; Biological Transport; Glioma; Humans; Kinetics; Male; Meningeal Neoplasms; Meningioma; Positron-Emission Tomography; Radioactive Tracers; Tyrosine | 2019 |
Comparison of [
Topics: Adult; Brain Neoplasms; Cohort Studies; Female; Fluorine Radioisotopes; Glioma; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Tyrosine | 2020 |
Quantitative parametric maps of O-(2-[
Topics: Adult; Aged; Brain Mapping; Brain Neoplasms; Fluorine Radioisotopes; Glioma; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Tyrosine; Young Adult | 2020 |
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Topics: Adult; Aged; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Tyrosine; Young Adult | 2019 |
Dynamic FET PET Imaging of a "Butterfly" IDH-Wildtype Anaplastic Astrocytoma.
Topics: Aged; Astrocytoma; Brain Neoplasms; Humans; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Tyrosine | 2019 |
Topics: Adult; Aged; Disease Progression; Female; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Tyrosine; Young Adult | 2020 |
Flare Phenomenon in
Topics: Adult; Aged; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Positron-Emission Tomography; Preoperative Period; Tyrosine | 2020 |
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Disease Progression; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Temozolomide; Tyrosine | 2021 |